Mark A. West

661 total citations
23 papers, 448 citations indexed

About

Mark A. West is a scholar working on Oncology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mark A. West has authored 23 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 8 papers in Pharmacology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mark A. West's work include Drug Transport and Resistance Mechanisms (18 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Mark A. West is often cited by papers focused on Drug Transport and Resistance Mechanisms (18 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Mark A. West collaborates with scholars based in United States, United Kingdom and China. Mark A. West's co-authors include Manthena V. S. Varma, Bo Feng, Chester Costales, Sarah Lazzaro, Yi‐An Bi, Larry M. Tremaine, Emi Kimoto, Jennifer L. Liras, Nandini C. Patel and Travis T. Wager and has published in prestigious journals such as Journal of Biological Chemistry, Clinical Infectious Diseases and Chemosphere.

In The Last Decade

Mark A. West

22 papers receiving 438 citations

Peers

Countries citing papers authored by Mark A. West

Since Specialization

Citations

This map shows the geographic impact of Mark A. West's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. West with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. West more than expected).

Fields of papers citing papers by Mark A. West

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. West. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. West. The network helps show where Mark A. West may publish in the future.

Co-authorship network of co-authors of Mark A. West

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. West. A scholar is included among the top collaborators of Mark A. West based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. West. Mark A. West is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Significance of gut breast cancer resistance protein versus organic anion transporting polypeptide 2B1 inhibition on rosuvastatin clinical drug-drug interactions 2025 ·Drug Metabolism and Disposition ·Mark A. West, Sarah Lazzaro, (unknown), Chester Costales, Sook Wah Yee, Manthena V. S. Varma	0
2	Cyclosporine A sterically inhibits statin transport by solute carrier OATP1B1 2025 ·Journal of Biological Chemistry ·Min Woo Sung, (unknown), Lea M. Hürlimann, Joshua A. Lees, Kimberly F. Fennell, Mark A. West, Chester Costales, A. David Rodrigues, Iwan Zimmermann, Roger Dawson, Shenping Liu, Seungil Han	2
3	Mechanistic Determinants of Daprodustat Drug–Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of OATP1B‐CYP2C8 Interplay 2024 ·Clinical Pharmacology & Therapeutics ·Yi‐An Bi, (unknown), Amanda King‐Ahmad, Mark A. West, Manthena V. S. Varma	5
4	Evaluation of 14 PFAS for permeability and organic anion transporter interactions: Implications for renal clearance in humans 2024 ·Chemosphere ·Sangwoo Ryu, Emi Yamaguchi, Seyed Mohamad Sadegh Modaresi, Juliana Agudelo, Chester Costales, Mark A. West, Fabian C. Fischer, Angela L. Slitt	20
5	Low Molecular Weight Acids and Organic Anion Transporting Polypeptide (OATP1B)-Mediated Hepatic Clearance: In Vitro and In Vivo Evaluation Using Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (Dustats) 2024 ·Drug Metabolism and Disposition ·Yi‐An Bi, (unknown), Amanda King‐Ahmad, Mark A. West, Emi Yamaguchi, Sangwoo Ryu, Sumathy Mathialagan, David A. Tess, Manthena V. S. Varma	1
6	Utilization of Rosuvastatin and Endogenous Biomarkers in Evaluating the Impact of Ritlecitinib on BCRP, OATP1B1, and OAT3 Transporter Activity 2023 ·Pharmaceutical Research ·(unknown), Anna Plotka, (unknown), Julia Kaplan, (unknown), (unknown), Vivek S. Purohit, Martin E. Dowty, Robert Wołk, Manoli Vourvahis, Amanda King‐Ahmad, Sumathy Mathialagan, Mark A. West, Sarah Lazzaro, Sangwoo Ryu, A. David Rodrigues	3
7	Translatability of in vitro Inhibition Potency to in vivo P-Glycoprotein Mediated Drug Interaction Risk 2023 ·Journal of Pharmaceutical Sciences ·Sarah Lazzaro, Mark A. West, (unknown), Bo Feng, Manthena V. S. Varma, A. David Rodrigues, (unknown), (unknown), (unknown), Zsuzsanna Gáborik, Chester Costales	5
8	Organic Anion–Transporting Polypeptide 1B1/1B3–Mediated Hepatic Uptake Determines the Pharmacokinetics of Large Lipophilic Acids: In Vitro–In Vivo Evaluation in Cynomolgus Monkey 2021 ·Journal of Pharmacology and Experimental Therapeutics ·Heather Eng, Yi‐An Bi, Mark A. West, Sangwoo Ryu, Emi Yamaguchi, Rachel E. Kosa, David A. Tess, David A. Griffith, John Litchfield, Amit S. Kalgutkar, Manthena V. S. Varma	15
9	Quantitative prediction of breast cancer resistant protein mediated drug‐drug interactions using physiologically‐based pharmacokinetic modeling 2021 ·CPT Pharmacometrics & Systems Pharmacology ·Chester Costales, Jian Lin, Emi Kimoto, Shinji Yamazaki, J Gosset, A. David Rodrigues, Sarah Lazzaro, Mark A. West, (unknown), Manthena V. S. Varma	39
10	Tissue Yields for Epidermal Growth Factor Receptor Analysis in Non-Small Cell Lung Cancer Patients in Trinidad and Tobago 2021 ·Cureus ·(unknown), Mark A. West	1
11	Biomarker‐Informed Model‐Based Risk Assessment of Organic Anion Transporting Polypeptide 1B Mediated Drug‐Drug Interactions 2021 ·Clinical Pharmacology & Therapeutics ·Emi Kimoto, Chester Costales, Mark A. West, Yi‐An Bi, Manoli Vourvahis, A. David Rodrigues, Manthena V. S. Varma	33
12	In Vitro–In Vivo Extrapolation of Key Transporter Activity at the Blood–Brain Barrier 2019 ·Drug Metabolism and Disposition ·Patrick Trapa, Matthew D. Troutman, (unknown), Travis T. Wager, Tristan S. Maurer, Nandini C. Patel, Mark A. West, John P. Umland, Anthony Carlo, Bo Feng, Jennifer L. Liras	28
13	Quantitative Contribution of Six Major Transporters to the Hepatic Uptake of Drugs: “SLC-Phenotyping” Using Primary Human Hepatocytes 2019 ·Journal of Pharmacology and Experimental Therapeutics ·Yi‐An Bi, Chester Costales, Sumathy Mathialagan, Mark A. West, (unknown), Sarah Lazzaro, Laurie Tylaska, Renato J. Scialis, Hui Zhang, John P. Umland, Emi Kimoto, David A. Tess, Bo Feng, Larry M. Tremaine, Manthena V. S. Varma, A. David Rodrigues	66
14	Validation of Human MDR1-MDCK and BCRP-MDCK Cell Lines to Improve the Prediction of Brain Penetration 2019 ·Journal of Pharmaceutical Sciences ·Bo Feng, Mark A. West, Nandini C. Patel, Travis T. Wager, Xinjun Hou, Jillian G. Johnson, Larry M. Tremaine, Jennifer L. Liras	55
15	Prediction of Human Brain Penetration of P-glycoprotein and Breast Cancer Resistance Protein Substrates Using In Vitro Transporter Studies and Animal Models 2018 ·Journal of Pharmaceutical Sciences ·Bo Feng, Angela C. Doran, Li Di, Mark A. West, Sarah M. Osgood, Jessica Mancuso, Christopher L. Shaffer, Larry M. Tremaine, Jennifer L. Liras	27
16	The Antimicrobial Agent Fusidic Acid Inhibits Organic Anion Transporting Polypeptide–Mediated Hepatic Clearance and May Potentiate Statin-Induced Myopathy 2016 ·Drug Metabolism and Disposition ·Heather Eng, Renato J. Scialis, Charles J. Rotter, Jun Lin, Sarah Lazzaro, Manthena V. S. Varma, Li Di, Bo Feng, Mark A. West, Amit S. Kalgutkar	23
17	Tumor P-Glycoprotein Correlates with Efficacy of PF-3758309 in in vitro and in vivo Models of Colorectal Cancer 2013 ·Frontiers in Pharmacology ·Erica L. Bradshaw‐Pierce, Todd M. Pitts, Aik Choon Tan, (unknown), Mark A. West, Daniel L. Gustafson, Charles Halsey, Leslie Nguyen, Nathan V. Lee, Julie L.C. Kan, Brion W. Murray, Sabine Eckhardt	29
18	Elucidation of the biochemical basis for a clinical drug–drug interaction between atorvastatin and 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methyl benzoic acid (CP-778 875), a subtype selective agonist of the peroxisome proliferator-activated receptor alpha 2013 ·Xenobiotica ·Amit S. Kalgutkar, Danny Chen, Manthena V. S. Varma, Bo Feng, Steven G. Terra, Renato J. Scialis, Charles J. Rotter, Kosea S. Frederick, Mark A. West, Theunis C. Goosen, J Gosset, Robert L. Walsky, Omar L. Francone	5
19	In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions 2013 ·Drug Metabolism and Disposition ·Eric L. Reyner, (unknown), Mark A. West, (unknown), (unknown), Katherine S. Fenner, Mohammed Ullah, Caroline A. Lee, Bill J. Smith	32
20	Serious Adverse Event After Unrecognized Substitution of One Amphotericin B Lipid Preparation for Another 1998 ·Clinical Infectious Diseases ·James R. Johnson, (unknown), Mark A. West	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact